These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Expression of matrix metalloproteinases and their endogenous tissue inhibitors in skin lesions from patients with tuberous sclerosis. Papakonstantinou E; Dionyssopoulos A; Aletras AJ; Pesintzaki C; Minas A; Karakiulakis G J Am Acad Dermatol; 2004 Oct; 51(4):526-33. PubMed ID: 15389186 [TBL] [Abstract][Full Text] [Related]
9. The Characterization of a Subependymal Giant Astrocytoma-Like Cell Line from Murine Astrocyte with mTORC1 Hyperactivation. Tang X; Angst G; Haas M; Yang F; Wang C Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33923449 [TBL] [Abstract][Full Text] [Related]
10. Surgical treatment of subependymal giant cell astrocytoma in tuberous sclerosis complex patients. Kotulska K; Borkowska J; Roszkowski M; Mandera M; Daszkiewicz P; Drabik K; Jurkiewicz E; Larysz-Brysz M; Nowak K; Grajkowska W; Domańska-Pakieła D; Jóźwiak S Pediatr Neurol; 2014 Apr; 50(4):307-12. PubMed ID: 24507694 [TBL] [Abstract][Full Text] [Related]
11. Congenital subependymal giant cell astrocytomas in patients with tuberous sclerosis complex. Kotulska K; Borkowska J; Mandera M; Roszkowski M; Jurkiewicz E; Grajkowska W; Bilska M; Jóźwiak S Childs Nerv Syst; 2014 Dec; 30(12):2037-42. PubMed ID: 25227171 [TBL] [Abstract][Full Text] [Related]
12. Pathogenesis of tuberous sclerosis subependymal giant cell astrocytomas: biallelic inactivation of TSC1 or TSC2 leads to mTOR activation. Chan JA; Zhang H; Roberts PS; Jozwiak S; Wieslawa G; Lewin-Kowalik J; Kotulska K; Kwiatkowski DJ J Neuropathol Exp Neurol; 2004 Dec; 63(12):1236-42. PubMed ID: 15624760 [TBL] [Abstract][Full Text] [Related]
13. Subependymal giant cell astrocytomas are characterized by mTORC1 hyperactivation, a very low somatic mutation rate, and a unique gene expression profile. Giannikou K; Zhu Z; Kim J; Winden KD; Tyburczy ME; Marron D; Parker JS; Hebert Z; Bongaarts A; Taing L; Long HW; Pisano WV; Alexandrescu S; Godlewski B; Nellist M; Kotulska K; Jozwiak S; Roszkowski M; Mandera M; Thiele EA; Lidov H; Getz G; Devinsky O; Lawrence MS; Ligon KL; Ellison DW; Sahin M; Aronica E; Meredith DM; Kwiatkowski DJ Mod Pathol; 2021 Feb; 34(2):264-279. PubMed ID: 33051600 [TBL] [Abstract][Full Text] [Related]
14. Solitary subependymal giant cell astrocytoma: Case report and review of the literature. Corlette L; Reid A; Roberts-Thomson S; Christie M; Gaillard F J Clin Neurosci; 2020 Dec; 82(Pt A):26-28. PubMed ID: 33317733 [TBL] [Abstract][Full Text] [Related]
15. Pathological Findings of a Subependymal Giant Cell Astrocytoma Following Treatment With Rapamycin. Cheng S; Hawkins C; Taylor MD; Bartels U Pediatr Neurol; 2015 Sep; 53(3):238-242.e1. PubMed ID: 26173783 [TBL] [Abstract][Full Text] [Related]
16. Experience using mTOR inhibitors for subependymal giant cell astrocytoma in tuberous sclerosis complex at a single facility. Tomoto K; Fujimoto A; Inenaga C; Okanishi T; Imai S; Ogai M; Fukunaga A; Nakamura H; Sato K; Obana A; Masui T; Arai Y; Enoki H BMC Neurol; 2021 Mar; 21(1):139. PubMed ID: 33784976 [TBL] [Abstract][Full Text] [Related]
17. Subependymal giant cell astrocytoma in a genetically negative tuberous sclerosis complex adult: Case report. Konakondla S; Jayarao M; Skrade J; Giannini C; Workman MJ; Morgan CJ Clin Neurol Neurosurg; 2016 Nov; 150():177-180. PubMed ID: 27690251 [TBL] [Abstract][Full Text] [Related]
18. Dose-level response rates of mTor inhibition in tuberous sclerosis complex (TSC) related subependymal giant cell astrocytoma (SEGA). Weidman DR; Pole JD; Bouffet E; Taylor MD; Bartels U Pediatr Blood Cancer; 2015 Oct; 62(10):1754-60. PubMed ID: 25929843 [TBL] [Abstract][Full Text] [Related]
19. Association between the growth rate of subependymal giant cell astrocytoma and age in patients with tuberous sclerosis complex. Tsai JD; Wei CC; Tsao TF; Hsiao YP; Tsai HJ; Yang SH; Tsai ML; Sheu JN Childs Nerv Syst; 2016 Jan; 32(1):89-95. PubMed ID: 26552385 [TBL] [Abstract][Full Text] [Related]
20. Isolated subependymal giant cell astrocytoma (SEGA) in the absence of clinical tuberous sclerosis: two case reports and literature review. Cobourn KD; Chesney KM; Mueller K; Fayed I; Tsering D; Keating RF Childs Nerv Syst; 2024 Jan; 40(1):73-78. PubMed ID: 37658938 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]